John D. Quisel, SVP, Corporate Development, GC & Secretary at ACCELERON PHARMA INC (XLRN), sold 4,505 shares at $38.29 ($172K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
Seasonal sale ($172k) by SVP, Corporate Development, GC & Secretary — this insider has traded XLRN in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| IRON | SELL | 2026-06-23 | $2.4M | — | Filing → |
| IRON | SELL | 2026-02-17 | $834K | — | Filing → |
| IRON | SELL | 2025-12-15 | $7.4M | — | Filing → |